RTMS Targets Neural Circuits for Smoking Cessation
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT04903028
- Status
- Recruiting
Conditions
- Cigarette Smoking
- Tobacco Use
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- Sham rTMS — DEVICETwo electrodes on the scalp will be connected to transcutaneous electrical nerve stimulation.
- Active rTMS 10 Hz DLPFC — DEVICE10 Hz repetitive transcranial magnetic stimulation (rTMS) will be delivered over left dorsolateral prefrontal cortex (DLPFC).
Study Details
Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, investigators will use brain MRI to guide TMS therapy for smoking cessation.
Key Dates
- Start date
- May 15, 2021
- Status verified
- Apr 2026
- Primary completion
- Feb 28, 2027
- Completion
- Apr 4, 2027
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Sham Comparator: Sham rTMSInvestigators will use electrode stimulation with 10 Hz over DLPFC, total 3000 pulses. The sham-TMS scalp discomfort was matched to that of active TMS. During real TMS there was no current flowing through the scalp electrodes.
- Active Comparator: Active rTMS 10 Hz DLPFCA stimulation frequency of 10 Hz, pulse train duration (on time) of 5 seconds, inter-train interval (off time) of 10 seconds (15 second cycle time), E-field-modeling to determine TMS intensity and coil orientation, total of 60 trains, session time of 15 minutes, and 3000-total pulses per day, will be delivered over the left DLPFC.
Primary Outcome Measure
4 week continue quit rate [ Time Frame: 20 weeks ]
Central Contacts
- Xingbao Li, MD, MSCR, MS843-792-5729
- Rebecca Keneally843-792-0136
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Xingbao Li, M.D (PRINCIPAL_INVESTIGATOR) |
| Medical University of South Carolina | Charleston | South Carolina | 29425 |
Find similar trials in Charleston, SC
By research site
Related Studies
- A Clinical Trial of Adaptive Treatment for Early Smoking Cessation RelapseRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Switch or Quit R01Recruiting · Medical University of South Carolina · Charleston, South Carolina
- Evaluation of Low and High Nicotine Tobacco Free Nicotine PouchesRecruiting · Medical University of South Carolina · Charleston, South Carolina
- STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for SmokingRecruiting · Medical University of South Carolina · Charleston, South Carolina